Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Chen Fu, Lifeng Yu, Yuxi Miao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 498-516
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Antibody–drug conjugates: Recent advances in payloads
Zhijia Wang, Hanxuan Li, Lantu Gou, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 10, pp. 4025-4059
Open Access | Times Cited: 97
Antibody–Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence
Pooja Gogia, Hamza Ashraf, S. Bhasin, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3886-3886
Open Access | Times Cited: 82
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
Janet M. Sasso, Rumiana Tenchov, Robert E. Bird, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 1951-2000
Open Access | Times Cited: 55
Research advances in peptide‒drug conjugates
Liming Gong, Heming Zhao, Yanhong Liu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3659-3677
Open Access | Times Cited: 54
Peptide Drug Conjugates and Their Role in Cancer Therapy
Ethan Heh, Jesse Allen, Fabiola Ramirez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 829-829
Open Access | Times Cited: 45
Bispecific antibody drug conjugates: Making 1+1>2
Yilin Gu, Zhijia Wang, Yuxi Wang
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1965-1986
Open Access | Times Cited: 34
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Jillian Belgrad, Hassan H. Fakih, Anastasia Khvorova
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 2, pp. 52-72
Closed Access | Times Cited: 32
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
Mo Wang, Jiawei Liu, Mingjing Xia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116119-116119
Closed Access | Times Cited: 29
An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction
Xinyu He, Jie Li, Xinxin Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 19
Injectable Chitosan Hydrogels Doped with 2D Peptide Nanosheet‐Drug Conjugates for Glutathione‐Responsive Sustained Drug Delivery
Xin Luan, Huiqiang Hu, Danzhu Zhu, et al.
Chemistry - A European Journal (2024) Vol. 30, Iss. 28
Closed Access | Times Cited: 18
Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic
Syed Faheem Askari Rizvi, Lin‐Jie Zhang, Haixia Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 309-334
Open Access | Times Cited: 17
Peptide-Drug Conjugates: A New Hope for Cancer Management
Vivek P. Chavda, Hetvi K. Solanki, Majid Davidson, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7232-7232
Open Access | Times Cited: 57
Strategies to improve the physicochemical properties of peptide-based drugs
Michelle Felicia Lee, Chit Laa Poh
Pharmaceutical Research (2023) Vol. 40, Iss. 3, pp. 617-632
Closed Access | Times Cited: 36
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities
Ritwik Maiti, Bhumika Patel, Nrupesh Patel, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 5, pp. 361-388
Open Access | Times Cited: 26
Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment
Juwon Yang, Hyunsu Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 9, pp. 1996-2004
Open Access | Times Cited: 25
Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
Xu Liu, Cheng Yang, Yao Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity
Yinghua Zeng, Xu Liao, Yuting Guo, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 838-848
Closed Access | Times Cited: 12
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Francisco Branco, Joana Cunha, Maria Mendes, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16359-16394
Open Access | Times Cited: 12
Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989
Othman Al Musaimi
Cancers (2024) Vol. 16, Iss. 5, pp. 1032-1032
Open Access | Times Cited: 11
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 11
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Abed Alqader Ibrahim, Hamdi Nsairat, Mazen Al-Sulaibi, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 3, pp. 399-422
Closed Access | Times Cited: 9
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
Baochen Zhang, Mo Wang, Li Sun, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11469-11487
Closed Access | Times Cited: 8
Overview of Peptides and Their Potential Roles in Skin Health and Beauty
Leyang Wang, Zhijing Wu, Xinyu Wang, et al.
Journal of Peptide Science (2025) Vol. 31, Iss. 2
Closed Access | Times Cited: 1
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top